logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
B

Bridgebio Pharma Inc, Palo Alto, California, United States

Scholars2
Papers1
Citations0
Related Papers (1)
Publication Date
delete
LB1248 Improving the therapeutic potential of intravenous recombinant collagen VII as a protein replacement therapy for recessive dystrophic epidermolysis bullosa
errJournal of Investigative Dermatology
IF5.7
err2025-07-21
err0
PREAI
errE. Eid; M. de Souza; K. Neelon; J.Y. Tang; M. Chen; D. Woodley; D. Keene; A. Nyström
errShare
errSave